Not Tagged
amgen
['biomarker', 'nsclc', 'lung', 'sclc', 'amgenoncology', 'amgen']
lung cancer biomarker testing can potentially lead to more information on treatment options. 1 in 8 people living with non-small cell lung cancer (#nsclc) have the kras g12c biomarker. that s why it s essential to share testing information &amp; expand access. #asco22
Advancing oncology at the speed of life™. Tweets intended for U.S. audience. See our Community Guidelines: https://t.co/WUbqtYa6KT.